Biopharma AI
ByInductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology Testing
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has been awarded up…
Pfizer Celebrates Innovation with 2025 AI Festival
Global – Pfizer hosted its second annual AI Festival Week, bringing together colleagues worldwide to explore the transformative…
Adaptive Biotechnologies and Pfizer Announce Strategic Research Collaboration Valued Up to $890 Million to Advance Breakthrough Therapies for Rheumatoid Arthritis and Immune-Mediated Diseases
A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis. A data licensing agreement to…
Is Merck and Nvidia’s KERMT Model the Breakthrough That Finally Makes AI-Native Drug Discovery Faster, Greener, and More Predictive?
Key Highlights / Executive Takeaways: • Merck and Nvidia introduce KERMT, a next-generation small-molecule AI model trained on…
Will the European Commission’s New Health Policy Package Accelerate Biotech, AI, and Medical Device Innovation?
The European Commission has unveiled a new health policy package to strengthen innovation, competitiveness, and resilience across the…
Are Galux and Boehringer Ingelheim Pioneering AI in Precision Protein Design?
December 17, 2025 — Galux, a South Korean biotech company focused on AI-driven protein therapeutics, has entered a…
